Eastgate Biotech Corp Analysis

ETBIDelisted Stock  USD 0  0.00  0.00%   
Eastgate Biotech Corp is overvalued with Real Value of 0.004085 and Hype Value of 0.005625. The main objective of Eastgate Biotech delisted stock analysis is to determine its intrinsic value, which is an estimate of what Eastgate Biotech Corp is worth, separate from its market price. There are two main types of Eastgate Biotech's stock analysis: fundamental analysis and technical analysis.
The Eastgate Biotech stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Eastgate Biotech's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Eastgate Stock Analysis Notes

The company recorded a loss per share of 0.01. Eastgate Biotech Corp had not issued any dividends in recent years. Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada. EASTGATE BIOTECH is traded on OTC Exchange in the United States. To learn more about Eastgate Biotech Corp call Rosella Perri at 647-692-0652 or check out https://www.EastGateBiotech.com.

Eastgate Biotech Corp Investment Alerts

Eastgate Biotech is not yet fully synchronised with the market data
Eastgate Biotech has some characteristics of a very speculative penny stock
Eastgate Biotech has a very high chance of going through financial distress in the upcoming years
Eastgate Biotech Corp currently holds 1.67 M in liabilities. Eastgate Biotech Corp has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Eastgate Biotech's use of debt, we should always consider it together with its cash and equity.
Net Loss for the year was (2.98 M) with profit before overhead, payroll, taxes, and interest of 0.
Eastgate Biotech Corp currently holds about 4.91 K in cash with (389.48 K) of positive cash flow from operations.

Eastgate Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 205.75 K.

Eastgate Biotech Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Eastgate Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Eastgate Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Eastgate Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Eastgate Biotech Outstanding Bonds

Eastgate Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Eastgate Biotech Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Eastgate bonds can be classified according to their maturity, which is the date when Eastgate Biotech Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Eastgate Biotech Predictive Daily Indicators

Eastgate Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Eastgate Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Eastgate Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eastgate Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eastgate shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Eastgate Biotech. By using and applying Eastgate Stock analysis, traders can create a robust methodology for identifying Eastgate entry and exit points for their positions.
Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada. EASTGATE BIOTECH is traded on OTC Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Eastgate Biotech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Eastgate Stock

If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios